Find a study online  


 

Study Details

Print Version

Title: PACtMD

What is the purpose of the study?
     Older adults with depression or mild cognitive impairment have a significantly elevated risk for Alzheimer's Dementia (AD), even if they do not yet show symptoms. However, there are currently no preventive treatments to protect these older adults against AD. This study is examining the combination of two novel interventions – transcranial direct current stimulation (tDCS) and cognitive remediation therapy – to protect against AD in patients with depression or mild cognitive impairment.

Who is needed?
     Individuals with: Mild Cognitive Impairment (MCI), History of Depression
     Individuals without
a mental health or
addiction problem: 

No

     Age range: over age 60
     Gender: All
     Ethnicity: All
     Other:



What does the study involve?
     Number of contacts:  multiple throughout the study
     Time period:  24-60 months
     Length of contacts: every visit differs (please see below)
     Treatment offered:

Yes

Location:

1001 Queen St. West (Queen site), GMHS Research, Unit 4-3

Principal Investigator:

Benoit Mulsant

Contact information:
     Phone: 416-583-1350
     e-mail: pact.md@camh.ca
     Website: www.camh.ca/en/research/research_areas/studies_and_recruitment/study-websites/Pages/PACt-MD.aspx
     Flyer:



Study end date:

31 May 2020

REB number: 14/2014
Full study title: Prevention of Alzheimer’s Dementia with Cognitive Remediation plus Transcranial Direct Current Stimulation in Mild Cognitive Impairment and Depression
Keywords: memory, depression, mood disorders, alzheimer's disease, dementia
Study Area: Alzheimer's Disease, Memory, Older adults

PLEASE NOTE:
  • Research staff cannot give medical advice over the phone.
  • If you have specific questions regarding your health care, please contact your family physician.
  • We regret that not everyone screened for a study will be eligible to participate
  • For more information about other treatment options for mental illness or addiction offered by CAMH, visit www.camh.ca or call 416-535-8501.
 



© 2018 CAMH | Terms of use